secwatch.observer — SEC 8-K summary
======================================

Issuer:     Verastem, Inc. (VSTM)
CIK:        0001526119
Form:       8-K
Filed at:   2021-10-26T23:59:59+00:00
Accession:  0001558370-21-013474
Event type: leadership
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Verastem appoints Michelle Robertson to Board, replacing Gina Consylman effective Nov 15, 2021
--------------------------------------------------------------------------------

- Michelle Robertson appointed as Class III director and audit committee chair, effective Nov 15, 2021.
- Gina Consylman resigned from Board and audit committee, effective same date, to focus on other duties.
- Robertson is CFO of Editas Medicine; previously CFO of Momenta Pharmaceuticals through J&J acquisition.
- Robertson receives stock option grant of 63,493 shares upon joining, plus standard director compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/0001558370-21-013474-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1526119/000155837021013474/vstm-20211021x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-21-013474

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer